newsfilter
← Interviews
a16z44 min

Food, Drugs, and Tech: 100 years of Public Health

Amy Abernethy, Vijay Pande

Fireside Chat, Interview

Established in 1906 to address public health crises, the FDA is currently transitioning its 20% GDP-regulated portfolio from legacy physical archives to a fully digital, data-informed infrastructure that leverages machine learning for food safety and pathogen tracking. While modernizing clinical trial frameworks through the 21st Century Cures Act to accommodate gene therapies and real-world evidence, the agency balances risk aversion with the urgent need to approve life-saving innovations like cell-cultured foods and AI-driven medical devices. This evolution positions the FDA to shift from reactive disease treatment to preventative longitudinal care, utilizing synthetic data and dynamic regulatory paradigms to manage emerging biological technologies over the next century.